[1]Chen GG, Li MY, He RL, et al.Identification of hepatitis B virusX gene mutation in Hong Kong patients with hepatocellular carcino-ma[J].J Clin Virol, 2005, 34 (1) ∶7-12.
|
[2]Tu H, Bonura C, Mouly H, et al.Biological impact of natural C-terminal deletions of hepatitis B virus X protein in hepatocellularcarcinoma[J].Cancer Res, 2001, 61 (21) ∶7803-7810.
|
[3]朱荣, 张慧萍, 凌玉琴, 等.慢性乙型肝炎组织病理学指标及病毒X基因变异与患者预后相关性研究[J].中华微生物与免疫学杂志, 2007, 27 (6) ∶513-518.
|
[4]邹光惠, 黄扭煊, 李用平, 等.原发性肝痛息者肝组织中乙型肝炎病毒x蛋白与p53蛋白的结合[J].临床肝胆病杂志, 1997, 13 (1) ∶19-21.
|
[5]Feitelson MA, Zhu MH, Duan LX, et al.Hepatitis B X antigenand p53 are associated in vitro and in liver tissues frompatients withprimary hepatocellular carcinoma[J].Oncogene, 1993, 8 (5) ∶1109-1117.
|
[6]Wang Y, Cui F, Lv Y, et a1.HBsAg and HBx knocked into the p2llocus causes hepatocellular carcinoma in mice[J].Hepatology, 2004, 39 (2) ∶318-324.
|
[7]郭双平, 王文亮, 翟宇强.HBV x基因真核表达载体的构建及对肝癌细胞恶性表型的影响[J].第四军医大学学报, 2001, 22 (13) ∶1161-1165.
|
[8]肖鸿敏, 任建林, 董菁.乙型肝炎病毒X蛋白在肝细胞癌发生中的作用机制[J].实用肝脏病杂志, 2009, 3 (12) ∶225-228.
|
[9]Misral KP, Mukherji A, Kumar V.The conserved amino-terminalregion (amino acids 1-20) of the hepatitis B virus X proteinshows a transrepression function[J].Virus Res, 2004, 105 (2) ∶157-165.
|
[10]Kun HJ, Jang KL.Natural variants of hepatitis B virus X proteinhave differential effects on the expression of cyclin-dependent ki-nase inhibitor P21 gene[J].Nucleic Acids Res, 2004, 32 (7) ∶2202-2213.
|
[11]王国戗, 牛菊霞, 贾安奎.C基因型HBV较B基因型HBV易引起肝炎慢性化的机制[J].临床肝胆病杂志, 2009, 5 (25) ∶338-339.
|
[1] | Liangying GAN, Li ZUO. Micro-elimination of hepatitis C virus infection in the hemodialysis population[J]. Journal of Clinical Hepatology, 2024, 40(4): 659-664. doi: 10.12449/JCH240403 |
[2] | Yu WANG, Wenge XING, Zhongfu LIU, Cong JIN. Advances in laboratory testing methods and strategies for hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2024, 40(4): 672-678. doi: 10.12449/JCH240405 |
[3] | Li ZHANG, Peng HU. Hepatitis C virus infection and organ transplantation[J]. Journal of Clinical Hepatology, 2024, 40(4): 665-671. doi: 10.12449/JCH240404 |
[4] | Peng MiLin, Xiao XinQiang, Jiang YongFang, Tian Yi, Xu Yun, Zhang Min, Wang WenLong, Peng Feng, Gong GuoZhong. Preliminary study on effect of hepatitis C virus nonstructural protein 5A on HIV LTR[J]. Journal of Clinical Hepatology, 2014, 30(2): 136-140. doi: 10.3969/j.issn.1001-5256.2014.02.010 |
[5] | Zhu FuSheng, Qin YuJie, Cheng ZhenJiang, Jiang PeiRong, Zhang LingHui. The impact of HBV/HCV coinfection on HBV DNA levels and the severity of liver diseases in HBV-infected patients undergoing hemodialysis[J]. Journal of Clinical Hepatology, 2013, 29(2): 136-137+141. |
[6] | Wang YuMing, Cheng Lin. Recent perspectives of Chinese medicine-based therapy for hepatitis B and C virus infection[J]. Journal of Clinical Hepatology, 2012, 28(11): 872-876. |
[7] | Nie HongMing, Chen JianJie, Dong HuiLin, Yang YuQi, Wang ChengBao, Li HongDing, Chen YiYun, Gao YueQiu. Analysis of clinical characteristics of the infection of HCV genotype 1 and non-genotype 1 in China[J]. Journal of Clinical Hepatology, 2012, 28(6): 439-442. |
[8] | Wang Yu, Zhang Ying, Jia ZhanSheng. Recent treatment advances for hepatitis C virus-related mixed cryoglobulinemia[J]. Journal of Clinical Hepatology, 2012, 28(8): 628-632. |
[9] | Yin Xiao, Wen Bo, Tan WenJie. Progress in the development and immunogenicity improvement of DNA vaccine against chronic HCV infection[J]. Journal of Clinical Hepatology, 2011, 27(1): 32-35. |
[10] | Tian Di, Xu XiaoYuan. Treatment of hepatitis C virus infection in HIV/HCV co-infected patients[J]. Journal of Clinical Hepatology, 2011, 27(5): 540-544. |
[11] | Gao LuHua, Nie QingHe. Detection of hepatitis C virus in the supernatant of human placenta trophoblastic cells and cell lysates[J]. Journal of Clinical Hepatology, 2011, 27(12): 1296-1300. |
[12] | Lou GuoHua, Liu YanNing, Yin ChunBen, Chen Feng, Jia ZhanSheng, Chen Zhi. Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid[J]. Journal of Clinical Hepatology, 2011, 27(1): 72-75. |
[13] | Yan Yan, Xiu BingShui, Yin JiMing, Zhang HeQiu, Li Zhuo. Evaluation of cross-reactive antibody response to hypervariable region 1 of hepatitis C virus[J]. Journal of Clinical Hepatology, 2011, 27(8): 818-820. |
[14] | Qi ZhongTian. Hepatitis C virus infection and its therapeutic drugs[J]. Journal of Clinical Hepatology, 2011, 27(1): 15-18+27. |
[15] | Yang RuiFeng, Wei Lai. Detection of hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2011, 27(1): 1-7. |
[16] | Jiang XiaoHua, Liu LingLing, Lei Chuang, Zhou QingPing. Effects of hepatitis C virus genotype 1b core protein on the gene expressions of Bax and Bcl-2 in HepG2 cells[J]. Journal of Clinical Hepatology, 2011, 27(5): 511-514. |
[17] | Sun MengNing, Lan HaiYun, Ma Yu, Zhao Ya, Lu: Xin, Yang Jing, Lei YingFeng, Yao Min, Kang Jian, Zhao MingGao, Wang AiQin, Yin Wen. Generation of conditionally controlled transgenic mice expressing hepatitis C virus NS3/4A protease[J]. Journal of Clinical Hepatology, 2011, 27(1): 76-80. |
[18] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[19] | Wen Ming, Xiao XinQiang, Gong GuoZhong. Hepatitis C virus NS5A protein stimulates TLR4 expression[J]. Journal of Clinical Hepatology, 2011, 27(1): 49-52. |
[20] | Chen LiDong, Cheng Jun, Hong Yuan, Zhang LianFeng, Han Li, Guo Jiang. Construction of the prokaryotic expression vector of NS5ATP4A gene and its expression[J]. Journal of Clinical Hepatology, 2010, 26(4): 371-373. |